Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

v3.21.2
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)
3 Months Ended 4 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2020
Sep. 30, 2021
General and operating expenses $ 386,940 $ 121,555 $ 122,555 $ 4,694,296
Loss from operations (386,940) (121,555) (122,555) (4,694,296)
Other income (expense):        
Interest earned on marketable securities held in Trust Account 18,214 20,204 20,204 82,072
Transaction costs associated with the Initial Public Offering   (715,720) (715,720)  
Change in fair value of derivative warrant liability 20,336,305     21,656,844
Total other income (expense), net 20,354,519 (695,516) (695,516) 21,738,916
Net income (loss) $ 19,967,579 $ (817,071) $ (818,071) $ 17,044,620
Class A Common stock        
Other income (expense):        
Weighted average shares outstanding of common stock, basic and diluted 33,421,570 7,628,837 6,156,605 33,421,570
Basic and diluted net income (loss) per common share $ 0.48 $ (0.05) $ (0.06) $ 0.41
Class B Common stock        
Other income (expense):        
Weighted average shares outstanding of common stock, basic and diluted 8,355,393 7,695,253 7,657,572 8,355,393
Basic and diluted net income (loss) per common share $ 0.48 $ (0.05) $ (0.06) $ 0.41